{
  "resourceType": "Bundle",
  "id": "cfsb9078061117831",
  "identifier": {
    "system": "https://www.gravitatehealth.eu/sid/doc",
    "value": "EU/1/16/1157/002"
  },
  "type": "document",
  "timestamp": "2017-06-23T08:38:00+02:00",
  "entry": [
    {
      "resource": {
        "resourceType": "Composition",
        "id": "cfsb5419150199436",
        "language": "no",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"no\" lang=\"no\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb5419150199436\"  (Language \"no\") </p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155538)</span></p><p><b>date</b>: 2015-02-07T13:28:17Z</p><p><b>author</b>: <a href=\"#Organization_cfsb6005885654359\">See above (Organization/cfsb6005885654359)</a></p><p><b>title</b>: TEST PURPOSES ONLY - Suliqua Vulcan ePI</p><p><b>confidentiality</b>: unrestricted</p></div>"
        },
        "status": "final",
        "type": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/",
              "code": "100000155538"
            }
          ],
          "text": "Package Leaflet"
        },
        "date": "2015-02-07T13:28:17Z",
        "author": [
          {
            "reference": "Organization/cfsb6005885654359"
          }
        ],
        "title": "TEST PURPOSES ONLY - Suliqua Vulcan ePI",
        "confidentiality": "unrestricted",
        "section": [
          {
            "title": "B. PAKNINGSVEDLEGG",
            "code": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/",
                  "code": "100000155538"
                }
              ],
              "text": "B. PAKNINGSVEDLEGG"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h1>Pakningsvedlegg: Informasjon til brukeren</h1></div>"
            }
          },
          {
            "title": "1. Hva Suliqua er og hva det brukes mot",
            "code": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/",
                  "code": "100000155538-1"
                }
              ],
              "text": "B. PAKNINGSVEDLEGG"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><span>1. Hva Suliqua er og hva det brukes mot</span><div class=\"avsnitt\">Suliqua er et diabeteslegemiddel til injeksjon som inneholder to aktive stoffer:<ul><li><div class=\"avsnitt\">insulin glargin: et langtidsvirkende insulin som hjelper til å kontrollere blodsukkeret (glukose) hele døgnet.</div></li><li><div class=\"avsnitt\">lixisenatid: en “GLP-1-analog” som hjelper kroppen med å øke sin egen insulinutskillelse ved økninger i blodsukkeret, samt forsinker opptak av sukker fra maten</div></li></ul></div><div class=\"avsnitt\">Suliqua brukes til å behandle voksne med type 2-diabetes, for å hjelpe å kontrollere blodsukkernivåer når de er for høye. Det gis sammen med metformin, når andre legemidler alene ikke klarer å kontrollere blodsukkeret ditt.</div><div class=\"avsnitt\">Dersom du bruker andre diabetesmedisiner må du diskutere med legen din om du skal slutte med det legemidlet når du starter med Suliqua.</div></div>"
            }
          },
          {
            "title": "2. Hva du må vite før du bruker Suliqua",
            "code": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/",
                  "code": "100000155538-2"
                }
              ],
              "text": "B. PAKNINGSVEDLEGG"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><span>2. Hva du må vite før du bruker Suliqua</span><div class=\"pil-kontraindikasjon seksjon\"><span class=\"tittel\">Bruk ikke Suliqua:</span><div class=\"avsnitt\"><ul><li><div class=\"avsnitt\">dersom du er allergisk overfor insulin glargin eller lixisenatid eller noen av de andre innholdsstoffene i dette legemidlet (listet opp i avsnitt 6).</div></li></ul></div></div><div class=\"pil-advarsel seksjon\"><span class=\"tittel\">Advarsler og forsiktighetsregler</span><div class=\"avsnitt\">Rådfør deg med lege, apotek eller sykepleier før du bruker Suliqua dersom:<ul><li><div class=\"avsnitt\">du har type 1-diabetes, da Suliqua brukes i behandling av type 2-diabetes og denne medisinen ikke vil være den rette for deg.</div></li><li><div class=\"avsnitt\">du har diabetisk ketoacidose (en diabeteskomplikasjon som oppstår når kroppen ikke kan bryte ned glukose på grunn av insulinmangel) da dette legemidlet ikke vil være det rette for deg.</div></li><li><div class=\"avsnitt\">du har et alvorlig mage-/tarmproblem, som for eksempel en sykdom i magemusklene som heter “gastroparese” og som fører til forsinket tømming av magen. Fordi Suliqua kan forårsake magebivirkninger er ikke medisinen undersøkt hos pasienter med alvorlige mage-/tarmproblemer. Vennligst les informasjonen vedrørende medisiner som ikke skal ligge for lenge i magen din i avsnittet «<b>Andre legemidler og Suliqua</b>».</div></li><li><div class=\"avsnitt\">du har alvorlig nyresykdom eller du er dialysepasient. Bruk av dette legemidlet er ikke anbefalt.</div></li></ul></div><div class=\"avsnitt\">Følg din leges instruksjoner nøye når det gjelder dosering, kontroll av blod og urin, kosthold og fysisk aktivitet (fysisk arbeid og trening) og injeksjonsteknikk.</div><div class=\"avsnitt\"><u>Vær spesielt oppmerksom på følgende:</u><ul><li><div class=\"avsnitt\">For lavt blodsukker (hypoglykemi). Dersom blodsukkeret ditt er for lavt, følg veiledningen for hypoglykemi (se informasjonen i boksen i slutten av dette pakningsvedlegget).</div></li><li><div class=\"avsnitt\">For høyt blodsukker (hyperglykemi). Dersom blodsukkeret ditt er for høyt, følg veiledningen for hyperglykemi (se informasjonen i boksen i slutten av dette pakningsvedlegget).</div></li><li><div class=\"avsnitt\">Forsikre deg om at du bruker riktig medisin. Du må alltid sjekke etiketten før hver injeksjon for å unngå forveksling mellom Suliqua og andre insulintyper.</div></li><li><div class=\"avsnitt\">Dersom du er svaksynt, vennligst se avsnitt 3.</div></li></ul></div><div class=\"avsnitt\"><u>Mens du bruker denne medisinen må du være oppmerksom på følgende og snakk med lege, apotek</u> <u>eller sykepleier før du bruker Suliqua:</u><ul><li><div class=\"avsnitt\">alvorlige smerter i mageregionen (abdomen) som ikke blir bedre. Dette kan være et tegn på betennelse i bukspyttkjertelen (akutt pankreatitt).</div></li><li><div class=\"avsnitt\">væsketap fra kroppen din (dehydrering), for eksempel ved oppkast og diaré. Det er viktig å unngå dehydrering ved å drikke rikelig med væske, spesielt under de første ukene av behandling med Suliqua.</div></li></ul></div><div class=\"avsnitt\"><u>Hudforandringer på injeksjonsstedet</u><br/>Injeksjonsstedet bør roteres for å forebygge hudforandringer som for eksempel kuler under huden. Det kan hende at insulinet ikke virker så godt hvis du injiserer det på et klumpete sted på huden (se Hvordan bruke Suliqua). Hvis du pleier å injisere på et klumpete område og vil endre injeksjonssted til et annet område, må du ta kontakt med legen din først. Legen din kan gi deg beskjed om å kontrollere blodsukkeret ditt mer nøye og å justere dosen på insulinet ditt eller andre legemidler du bruker mot diabetes.</div><div class=\"avsnitt\"><u>Reiser</u><br/>Rådfør deg med legen din før du skal ut og reise. Det kan være nødvendig å ta opp:<ul><li><div class=\"avsnitt\">Tilgjengeligheten av din type medisin i det landet du besøker.</div></li><li><div class=\"avsnitt\">Forsyninger av medisinen din, sprøyter osv.</div></li><li><div class=\"avsnitt\">Riktig oppbevaring av medisinen under reisen.</div></li><li><div class=\"avsnitt\">Tidspunkt for måltider og medisinering under reisen.</div></li><li><div class=\"avsnitt\">Eventuelle følger av å krysse tidssoner.</div></li><li><div class=\"avsnitt\">Eventuelle nye helsefarer i de land du besøker.</div></li><li><div class=\"avsnitt\">Hva du skal gjøre i nødsituasjoner dersom du føler deg uvel eller blir syk.</div></li></ul></div></div><div class=\"pil-barn-unge seksjon\"><span class=\"tittel\">Barn og ungdom</span><div class=\"avsnitt\">Det er ikke erfaring med bruk av Suliqua hos barn og ungdom under 18 år. Suliqua anbefales derfor ikke brukt i denne aldersgruppen.</div></div><div class=\"pil-interaksjon seksjon\"><span class=\"tittel\">Andre legemidler og Suliqua</span><div class=\"avsnitt\">Rådfør deg med lege eller apotek dersom du bruker, nylig har brukt eller planlegger å bruke andre legemidler.</div><div class=\"avsnitt\">Enkelte legemidler kan forårsake en endring i blodsukkernivået ditt. Dette kan bety at Suliqua-dosen må endres. Før du begynner å ta et legemiddel må du derfor spørre legen din om det vil påvirke blodsukkeret ditt og hva du eventuelt må gjøre. Vær også oppmerksom når du skal slutte å ta et annet legemiddel.</div><div class=\"avsnitt\">Effekten av enkelte legemidler som svelges, kan påvirkes av Suliqua. Det kan være nødvendig å ta enkelte legemidler, som for eksempel antibiotika, p-piller, statiner (medisiner som atorvastatin som senker kolesterolet), magesaftresistente tabletter eller kapsler som ikke bør være for lenge i magen, minst én time før eller fire timer etter Suliqua-injeksjon.</div><div class=\"avsnitt\"><u>Ditt blodsukkernivå kan synke (hypoglykemi) dersom du tar:</u><ul><li><div class=\"avsnitt\">Alle andre medisiner for behandling av diabetes.</div></li><li><div class=\"avsnitt\">Disopyramid, brukes ved visse hjerteproblemer.</div></li><li><div class=\"avsnitt\">Fluoksetin, brukes ved depresjon.</div></li><li><div class=\"avsnitt\">Antibiotika av typen sulfonamider, brukes ved infeksjoner.</div></li><li><div class=\"avsnitt\">Fibrater, brukes for å senke høye nivåer av blodlipider.</div></li><li><div class=\"avsnitt\">Legemidler som hemmer enzymet monoaminoksidase (MAO), brukes ved depresjon eller Parkinsons sykdom.</div></li><li><div class=\"avsnitt\">Legemidler som hemmer angiotensinkonverterende enzym (ACE), brukes ved visse hjerteproblemer eller høyt blodtrykk.</div></li><li><div class=\"avsnitt\">Smertestillende og febernedsettende, som pentoksyfyllin, propoksyfen, salisylater (for eksempel acetylsalisylsyre).</div></li><li><div class=\"avsnitt\">Pentamidin, mot visse parasittinfeksjoner. Dette kan forårsake for lave blodsukkernivåer som noen ganger etterfølges av for høye blodsukkernivåer.</div></li></ul></div><div class=\"avsnitt\"><u>Ditt blodsukkernivå kan øke (hyperglykemi) dersom du tar:</u><ul><li><div class=\"avsnitt\">Kortikosteroider som kortison og prednisolon, brukes ved betennelsestilstander.</div></li><li><div class=\"avsnitt\">Danazol, brukes ved endometriose.</div></li><li><div class=\"avsnitt\">Diazoksid, brukes ved høyt blodtrykk.</div></li><li><div class=\"avsnitt\">Proteasehemmere, brukes ved HIV.</div></li><li><div class=\"avsnitt\">Vanndrivende, brukes ved høyt blodtrykk eller væske i kroppen.</div></li><li><div class=\"avsnitt\">Glukagon, brukes ved veldig lavt blodsukker.</div></li><li><div class=\"avsnitt\">Isoniazid, brukes ved tuberkulose.</div></li><li><div class=\"avsnitt\">Somatropin, et veksthormon.</div></li><li><div class=\"avsnitt\">Thyreoideahormoner, brukes ved sykdom i skjoldbruskkjertelen.</div></li><li><div class=\"avsnitt\">Østrogener og progesteroner, for eksempel i p-piller brukt som prevensjon eller østrogener mot benskjørhet (osteoporose).</div></li><li><div class=\"avsnitt\">Klozapin, olanzapin og fenotiazinderivater, brukes ved psykiatriske lidelser.</div></li><li><div class=\"avsnitt\">Såkalte sympatomimetika, som adrenalin, salbutamol og terbutalin, brukes ved astma.</div></li></ul></div><div class=\"avsnitt\"><u>Blodsukkernivået kan enten synke eller øke hvis du tar:</u><ul><li><div class=\"avsnitt\">Betablokkere eller klonidin, brukes ved høyt blodtrykk.</div></li><li><div class=\"avsnitt\">Litiumsalter, brukes ved psykiatriske lidelser.</div></li></ul></div><div class=\"avsnitt\"><u>Medisiner som kan redusere varselssymptomer på lavt blodsukker</u><br/>Betablokkere og noen andre legemidler (for eksempel klonidin, guanetidin og reserpin mot høyt blodtrykk) kan gjøre det vanskeligere å gjenkjenne varselsymptomene ved for lavt blodsukker (hypoglykemi). Det kan til og med skjule eller hemme de første symptomene på at ditt blodsukker er for lavt.</div><div class=\"avsnitt\">Dersom noe av det over gjelder deg (eller du ikke er sikker), snakk med legen din, apotek eller sykepleier før du bruker denne medisinen.</div><div class=\"avsnitt\"><u>Warfarin og andre blodfortynnende (antikoagulantia)</u><br/>Gi beskjed til legen din dersom du bruker warfarin eller andre antikoagulantia (medisiner som brukes for å forebygge blodpropp) fordi du kanskje må ta hyppigere blodprøver (disse heter ‘International Normalised Ratio’ eller INR-test) for å sjekke din blodlevring (koagulering).</div></div><div class=\"pil-mat-drikke seksjon\"><span class=\"tittel\">Suliqua sammen med alkohol</span><div class=\"avsnitt\">Blodsukkernivået ditt kan enten øke eller synke hvis du drikker alkohol. Du bør kontrollere blodsukkeret ditt oftere.</div></div><div class=\"pil-graviditet-amming-fertilitet seksjon\"><span class=\"tittel\">Graviditet og amming</span><div class=\"avsnitt\">Suliqua skal ikke brukes under graviditet. Det er ikke kjent om Suliqua kan skade ditt ufødte barn. Suliqua skal ikke brukes under amming. Det er ikke kjent om Suliqua går over i morsmelk.</div><div class=\"avsnitt\">Rådfør deg med lege eller apotek før du tar dette legemidlet dersom du er gravid eller ammer, tror at du kan være gravid eller planlegger å bli gravid.</div></div><div class=\"pil-bil-maskiner seksjon\"><span class=\"tittel\">Kjøring og bruk av maskiner</span><div class=\"avsnitt\">For lavt eller for høyt blodsukker (se informasjonen i boksen i slutten av dette pakningsvedlegget) kan påvirke din evne til å kjøre bil eller bruke maskiner. Konsentrasjonen din kan påvirkes. Dette kan være farlig for deg selv og andre.</div><div class=\"avsnitt\">Spør legen din om du kan kjøre dersom:<ul><li><div class=\"avsnitt\">Blodsukkeret ditt ofte er for lavt.</div></li><li><div class=\"avsnitt\">Du synes det er vanskelig å kjenne når blodsukkeret ditt er for lavt.</div></li></ul></div></div><div class=\"pil-innholdsstoffer seksjon\"><span class=\"tittel\">Viktig informasjon om noen av ingrediensene i Suliqua</span><div class=\"avsnitt\">Dette legemiddelet inneholder mindre enn 1 mmol (23 mg) natrium per dose, dvs. så godt som<br/>«natriumfritt».<br/>Dette legemidlet inneholder metakresol som kan forårsake allergiske reaksjoner.</div></div></div>"
            }
          },
          {
            "title": "3. Hvordan du bruker Suliqua",
            "code": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/",
                  "code": "100000155538-3"
                }
              ],
              "text": "B. PAKNINGSVEDLEGG"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><span>3. Hvordan du bruker Suliqua</span></div>"
            }
          },
          {
            "title": "4. Mulige bivirkninger",
            "code": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/",
                  "code": "100000155538-4"
                }
              ],
              "text": "B. PAKNINGSVEDLEGG"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><span>4. Mulige bivirkninger</span></div>"
            }
          },
          {
            "title": "5. Hvordan du oppbevarer Suliqua",
            "code": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/",
                  "code": "100000155538-2"
                }
              ],
              "text": "B. PAKNINGSVEDLEGG"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><span>5. Hvordan du oppbevarer Suliqua</span></div>"
            }
          },
          {
            "title": "6. Innholdet i pakningen og ytterligere informasjon",
            "code": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/",
                  "code": "100000155538-2"
                }
              ],
              "text": "B. PAKNINGSVEDLEGG"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><span>6. Innholdet i pakningen og ytterligere informasjon</span></div>"
            }
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "Organization",
        "id": "cfsb6005885654359",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb6005885654359\" </p></div><p><b>identifier</b>: id: ORG-100000789 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#bus)</span></p><p><b>name</b>: Sanofi-Aventis Groupe</p><p><b>address</b>: 54 Rue La Boetie  Paris  75008  France(WORK)</p></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/rmswi/#/",
            "value": "ORG-100000789"
          }
        ],
        "active": true,
        "type": [
          {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi/",
                "code": "/#bus"
              }
            ],
            "text": "Marketing authorisation holder"
          }
        ],
        "name": "Sanofi-Aventis Groupe",
        "address": [
          {
            "use": "work",
            "type": "physical",
            "text": "54 Rue La Boetie  Paris  75008  France",
            "line": [
              "54 Rue La Boetie"
            ],
            "city": "Paris",
            "country": "fr"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "Organization",
        "id": "cfsb2176224411725",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb2176224411725\" </p></div><p><b>identifier</b>: id: ORG-100001175 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer API <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#220000000033)</span></p><p><b>name</b>: Sanofi-Aventis Deutschland GmbH</p><p><b>address</b>: Brueningstrasse 50, Industriepark Höchst, 65926 Frankfurt am Main, GERMANY(WORK)</p></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/omswi/#/",
            "value": "ORG-100001175"
          }
        ],
        "active": true,
        "type": [
          {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi/",
                "code": "/#220000000033"
              }
            ],
            "text": "Manufacturer API"
          }
        ],
        "name": "Sanofi-Aventis Deutschland GmbH",
        "address": [
          {
            "use": "work",
            "type": "physical",
            "text": "Brueningstrasse 50, Industriepark Höchst, 65926 Frankfurt am Main, GERMANY",
            "line": [
              "Brueningstrasse 50, Industriepark Höchst"
            ],
            "city": "Frankfurt am Main",
            "postalCode": "65926",
            "country": "de"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "Organization",
        "id": "cfsb7719260512249",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb7719260512249\" </p></div><p><b>identifier</b>: id: ORG-100001175 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer Batch release <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#220000000033)</span></p><p><b>name</b>: Sanofi-Aventis Deutschland GmbH</p><p><b>address</b>: Brueningstrasse 50, Industriepark Höchst, 65926 Frankfurt am Main, GERMANY(WORK)</p></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/omswi/#/",
            "value": "ORG-100001175"
          }
        ],
        "active": true,
        "type": [
          {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi/",
                "code": "/#220000000033"
              }
            ],
            "text": "Manufacturer Batch release"
          }
        ],
        "name": "Sanofi-Aventis Deutschland GmbH",
        "address": [
          {
            "use": "work",
            "type": "physical",
            "text": "Brueningstrasse 50, Industriepark Höchst, 65926 Frankfurt am Main, GERMANY",
            "line": [
              "Brueningstrasse 50, Industriepark Höchst"
            ],
            "city": "Frankfurt am Main",
            "postalCode": "65926",
            "country": "de"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "Organization",
        "id": "cfsb1639015880655",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb1639015880655\" </p></div><p><b>identifier</b>: id: ORG-100013412 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Medicines Regulatory Authority <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#220000000033)</span></p><p><b>name</b>: European Medicines Agency</p><p><b>address</b>: Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands(WORK)</p></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/omswi/#/",
            "value": "ORG-100013412"
          }
        ],
        "active": true,
        "type": [
          {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi/",
                "code": "/#220000000033"
              }
            ],
            "text": "Medicines Regulatory Authority"
          }
        ],
        "name": "European Medicines Agency",
        "address": [
          {
            "use": "work",
            "type": "physical",
            "text": "Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands",
            "line": [
              "Carretera De Martorell 41 61, Poligono Industrial Nord-Est"
            ],
            "city": "Amsterdam",
            "postalCode": "1083 HS",
            "country": "nl"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "RegulatedAuthorization",
        "id": "cfsb9631820498004",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb9631820498004\" </p></div><p><b>identifier</b>: id: EU/1/16/1157/002 (OFFICIAL)</p><p><b>subject</b>: <a href=\"#MedicinalProductDefinition_cfsb1151803027115\">See above (MedicinalProductDefinition/cfsb1151803027115)</a></p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072062)</span></p><p><b>description</b>: Suliqua 100 units/ml + 50 microgram/ml solution for injection in a pre-filled pen</p><p><b>region</b>: European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#eu)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2017-01-11T13:28:17Z</p><p><b>validityPeriod</b>: 2017-01-11T13:28:17Z --&gt; (ongoing)</p><p><b>holder</b>: <a href=\"#Organization_cfsb6005885654359\">See above (Organization/cfsb6005885654359)</a></p><p><b>regulator</b>: <a href=\"#Organization_cfsb1639015880655\">See above (Organization/cfsb1639015880655)</a></p></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/rmswi/#/",
            "value": "EU/1/16/1157/002"
          }
        ],
        "subject": [
          {
            "reference": "MedicinalProductDefinition/cfsb1151803027115"
          }
        ],
        "type": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072062"
            }
          ],
          "text": "Marketing Authorisation"
        },
        "description": "Suliqua 100 units/ml + 50 microgram/ml solution for injection in a pre-filled pen",
        "region": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "eu"
              }
            ],
            "text": "European Union"
          }
        ],
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "active"
            }
          ],
          "text": "Active"
        },
        "statusDate": "2017-01-11T13:28:17Z",
        "validityPeriod": {
          "start": "2017-01-11T13:28:17Z"
        },
        "holder": {
          "reference": "Organization/cfsb6005885654359"
        },
        "regulator": {
          "reference": "Organization/cfsb1639015880655"
        }
      }
    },
    {
      "resource": {
        "resourceType": "MedicinalProductDefinition",
        "id": "cfsb1151803027115",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb1151803027115\" </p></div><p><b>identifier</b>: id: EU/1/16/1157/002 (OFFICIAL)</p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072062)</span></p><p><b>domain</b>: Human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000000012)</span></p><p><b>version</b>: 1</p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07T13:28:17Z</p><p><b>description</b>: Suliqua 100 units/ml + 50 microgram/ml solution for injection in a pre-filled pen:\nEach pre-filled pen contains 300 units of insulin glargine* and 150 micrograms lixisenatide in 3 ml solution.\nEach ml contains 100 units of insulin glargine and 50 micrograms lixisenatide.\nEach dose step contains 1 unit of insulin glargine and 0.5 micrograms of lixisenatide</p><p><b>route</b>: Subcutaneous use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000073633)</span></p><p><b>indication</b>: Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors.</p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072084)</span></p><p><b>classification</b>: insulin glargine and lixisenatide <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#A10AE54)</span>, Diabetes mellitus inadequate control <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000019249)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Suliqua 100 units/ml + 50 micrograms/ml solution for injection in a pre-filled pen</p><p><b>type</b>: Full name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#220000000001)</span></p><h3>NameParts</h3><table class=\"grid\"><tr><td>-</td><td><b>Part</b></td><td><b>Type</b></td></tr><tr><td>*</td><td>Solution for injection</td><td>Pharmaceutical dose form part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#220000000005)</span></td></tr></table><h3>CountryLanguages</h3><table class=\"grid\"><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#eu)</span></td><td>European Union <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#eu)</span></td><td>English <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.0.0/CodeSystem-v3-ietf3066.html\">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/pmswi/#/",
            "value": "EU/1/16/1157/002"
          }
        ],
        "type": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072062"
            }
          ],
          "text": "Marketing Authorisation"
        },
        "domain": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000000012"
            }
          ],
          "text": "Human use"
        },
        "version": "1",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "active",
              "display": "Active"
            }
          ]
        },
        "statusDate": "2015-02-07T13:28:17Z",
        "description": "Suliqua 100 units/ml + 50 microgram/ml solution for injection in a pre-filled pen:\nEach pre-filled pen contains 300 units of insulin glargine* and 150 micrograms lixisenatide in 3 ml solution.\nEach ml contains 100 units of insulin glargine and 50 micrograms lixisenatide.\nEach dose step contains 1 unit of insulin glargine and 0.5 micrograms of lixisenatide",
        "route": [
          {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi/",
                "code": "/#100000073633"
              }
            ],
            "text": "Subcutaneous use"
          }
        ],
        "indication": "Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors.",
        "legalStatusOfSupply": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072084"
            }
          ],
          "text": "Medicinal product subject to medical prescription"
        },
        "classification": [
          {
            "coding": [
              {
                "system": "https://www.whocc.no/atc_ddd_index/",
                "code": "A10AE54"
              }
            ],
            "text": "insulin glargine and lixisenatide"
          },
          {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi/",
                "code": "/#100000019249"
              }
            ],
            "text": "Diabetes mellitus inadequate control"
          }
        ],
        "name": [
          {
            "productName": "Suliqua 100 units/ml + 50 micrograms/ml solution for injection in a pre-filled pen",
            "type": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/rmswi/",
                  "code": "/#220000000001"
                }
              ],
              "text": "Full name"
            },
            "namePart": [
              {
                "part": "Solution for injection",
                "type": {
                  "coding": [
                    {
                      "system": "https://spor.ema.europa.eu/rmswi/",
                      "code": "/#220000000005"
                    }
                  ],
                  "text": "Pharmaceutical dose form part"
                }
              }
            ],
            "countryLanguage": [
              {
                "country": {
                  "coding": [
                    {
                      "system": "urn:iso:std:iso:3166",
                      "code": "eu"
                    }
                  ],
                  "text": "European Union"
                },
                "jurisdiction": {
                  "coding": [
                    {
                      "system": "urn:iso:std:iso:3166",
                      "code": "eu"
                    }
                  ],
                  "text": "European Union"
                },
                "language": {
                  "coding": [
                    {
                      "system": "urn:ietf:bcp:47",
                      "code": "en"
                    }
                  ],
                  "text": "English"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "PackagedProductDefinition",
        "id": "cfsb2900611666086",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb2900611666086\" </p></div><p><b>identifier</b>: id: EU/1/16/1157/002 (OFFICIAL)</p><p><b>name</b>: 3 ml cartridge (glass) in a pre-filled pen</p><p><b>type</b>: Chemical Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000155527)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07T13:28:17Z</p><p><b>containedItemQuantity</b>: 3 ml</p><p><b>description</b>: Type I colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with inserted laminated sealing disks (bromobutyl rubber on the medicinal product side and polyisoprene on the outside) containing 3 ml of solution. Each cartridge is assembled into a disposable pen.</p><p><b>copackagedIndicator</b>: false</p><p><b>manufacturer</b>: <a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></p><h3>Packages</h3><table class=\"grid\"><tr><td>-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td>*</td><td>id: EU/1/16/1157/002 (OFFICIAL)</td><td>Pre-filled pen <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000073543)</span></td><td>3</td><td>Glass type I <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#200000003204)</span></td></tr></table></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/pmswi/#/",
            "value": "EU/1/16/1157/002"
          }
        ],
        "name": "3 ml cartridge (glass) in a pre-filled pen",
        "type": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000155527"
            }
          ],
          "text": "Chemical Medicinal Product"
        },
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "active",
              "display": "Active"
            }
          ]
        },
        "statusDate": "2015-02-07T13:28:17Z",
        "containedItemQuantity": [
          {
            "value": 3,
            "unit": "ml"
          }
        ],
        "description": "Type I colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with inserted laminated sealing disks (bromobutyl rubber on the medicinal product side and polyisoprene on the outside) containing 3 ml of solution. Each cartridge is assembled into a disposable pen.",
        "copackagedIndicator": false,
        "manufacturer": [
          {
            "reference": "Organization/cfsb2176224411725"
          }
        ],
        "package": {
          "identifier": [
            {
              "use": "official",
              "system": "https://spor.ema.europa.eu/rmswi/#/",
              "value": "EU/1/16/1157/002"
            }
          ],
          "type": {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/rmswi/",
                "code": "/#100000073543"
              }
            ],
            "text": "Pre-filled pen"
          },
          "quantity": 3,
          "material": [
            {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/rmswi/",
                  "code": "/#200000003204"
                }
              ],
              "text": "Glass type I"
            }
          ]
        }
      }
    },
    {
      "resource": {
        "resourceType": "AdministrableProductDefinition",
        "id": "cfsb3361388689784",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb3361388689784\" </p></div><p><b>identifier</b>: id: TBD (OFFICIAL)</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href=\"#MedicinalProductDefinition_cfsb1151803027115\">See above (MedicinalProductDefinition/cfsb1151803027115)</a></p><p><b>administrableDoseForm</b>: Solution for injection <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000073863)</span></p><p><b>unitOfPresentation</b>: Pen <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#200000002135)</span></p><p><b>producedFrom</b>: <a href=\"#ManufacturedItemDefinition_cfsb6176453266374\">See above (ManufacturedItemDefinition/cfsb6176453266374)</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Subcutaneous use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000073633)</span></p><h3>TargetSpecies</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Human <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000109093)</span></td></tr></table></blockquote></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/pmswi/#/",
            "value": "TBD"
          }
        ],
        "status": "active",
        "formOf": [
          {
            "reference": "MedicinalProductDefinition/cfsb1151803027115"
          }
        ],
        "administrableDoseForm": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "100000073863"
            }
          ],
          "text": "Solution for injection"
        },
        "unitOfPresentation": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#200000002135"
            }
          ],
          "text": "Pen"
        },
        "producedFrom": [
          {
            "reference": "ManufacturedItemDefinition/cfsb6176453266374"
          }
        ],
        "routeOfAdministration": [
          {
            "code": {
              "coding": [
                {
                  "system": "https://spor.ema.europa.eu/rmswi/",
                  "code": "100000073633"
                }
              ],
              "text": "Subcutaneous use"
            },
            "targetSpecies": [
              {
                "code": {
                  "coding": [
                    {
                      "system": "https://spor.ema.europa.eu/rmswi/",
                      "code": "/#100000109093"
                    }
                  ],
                  "text": "Human"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "ManufacturedItemDefinition",
        "id": "cfsb6176453266374",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb6176453266374\" </p></div><p><b>identifier</b>: id: EU/1/16/1157/002 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Solution <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#200000002007)</span></p><p><b>unitOfPresentation</b>: Pen <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#200000002135)</span></p><p><b>manufacturer</b>: <a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></p></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/pmswi/#/",
            "value": "EU/1/16/1157/002"
          }
        ],
        "status": "active",
        "manufacturedDoseForm": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#200000002007"
            }
          ],
          "text": "Solution"
        },
        "unitOfPresentation": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#200000002135"
            }
          ],
          "text": "Pen"
        },
        "manufacturer": [
          {
            "reference": "Organization/cfsb2176224411725"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb3768802370375",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb3768802370375\" </p></div><p><b>identifier</b>: id: 2ZM8CX04RZ (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#00000072072)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class=\"grid\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>100 units/ml</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (v3-RoleClassIngredientEntity#ACTIB)</span></td></tr></table></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "2ZM8CX04RZ"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#00000072072"
            }
          ],
          "text": "active"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "2ZM8CX04RZ",
                  "display": "Insulin glargine"
                }
              ]
            }
          },
          "strength": [
            {
              "presentationQuantity": {
                "value": 100,
                "unit": "units/ml"
              },
              "basis": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity",
                    "code": "ACTIB"
                  }
                ],
                "text": "active ingredient - basis of strength"
              }
            }
          ]
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb8724428384435",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb8724428384435\" </p></div><p><b>identifier</b>: id: 74O62BB01U (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#00000072072)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class=\"grid\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>50 ug/ml</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (v3-RoleClassIngredientEntity#ACTIB)</span></td></tr></table></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "74O62BB01U"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#00000072072"
            }
          ],
          "text": "active"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "74O62BB01U",
                  "display": "Lixisenatide"
                }
              ]
            }
          },
          "strength": [
            {
              "presentationQuantity": {
                "value": 50,
                "unit": "ug/ml"
              },
              "basis": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity",
                    "code": "ACTIB"
                  }
                ],
                "text": "active ingredient - basis of strength"
              }
            }
          ]
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb8364716455502",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb8364716455502\" </p></div><p><b>identifier</b>: id: 74O62BB01U (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#00000072072)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class=\"grid\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>33 ug/ml</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (v3-RoleClassIngredientEntity#ACTIB)</span></td></tr></table></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "74O62BB01U"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#00000072072"
            }
          ],
          "text": "active"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "74O62BB01U",
                  "display": "Lixisenatide"
                }
              ]
            }
          },
          "strength": [
            {
              "presentationQuantity": {
                "value": 33,
                "unit": "ug/ml"
              },
              "basis": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity",
                    "code": "ACTIB"
                  }
                ],
                "text": "active ingredient - basis of strength"
              }
            }
          ]
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb7644964356957",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb7644964356957\" </p></div><p><b>identifier</b>: id: PDC6A3C0OX (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "PDC6A3C0OX"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072082"
            }
          ],
          "text": "Excipient"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "PDC6A3C0OX",
                  "display": "Glycerol"
                }
              ]
            }
          }
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb8873568628101",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb8873568628101\" </p></div><p><b>identifier</b>: id: AE28F7PNPL (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "AE28F7PNPL"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072082"
            }
          ],
          "text": "Excipient"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "AE28F7PNPL",
                  "display": "Methionine"
                }
              ]
            }
          }
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb7194634205639",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb7194634205639\" </p></div><p><b>identifier</b>: id: GGO4Y809LO (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "GGO4Y809LO"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072082"
            }
          ],
          "text": "Excipient"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "GGO4Y809LO",
                  "display": "Metacresol"
                }
              ]
            }
          }
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb9561966749493",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb9561966749493\" </p></div><p><b>identifier</b>: id: 86Q357L16B (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "86Q357L16B"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072082"
            }
          ],
          "text": "Excipient"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "86Q357L16B",
                  "display": "Zinc chloride"
                }
              ]
            }
          }
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb1268193754623",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb1268193754623\" </p></div><p><b>identifier</b>: id: QTT17582CB (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "QTT17582CB"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072082"
            }
          ],
          "text": "Excipient"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "QTT17582CB",
                  "display": "Concentrated hydrochloric acid"
                }
              ]
            }
          }
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb3286639616821",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb3286639616821\" </p></div><p><b>identifier</b>: id: 55X04QC32I (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "55X04QC32I"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072082"
            }
          ],
          "text": "Excipient"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "55X04QC32I",
                  "display": "Sodium hydroxide"
                }
              ]
            }
          }
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "cfsb7034777237464",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb7034777237464\" </p></div><p><b>identifier</b>: id: 059QF0KO0R (OFFICIAL)</p><p><b>status</b>: active</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_cfsb2176224411725\">See above (Organization/cfsb2176224411725)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
        },
        "identifier": {
          "use": "official",
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
          "value": "059QF0KO0R"
        },
        "status": "active",
        "role": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/rmswi/",
              "code": "/#100000072082"
            }
          ],
          "text": "Excipient"
        },
        "allergenicIndicator": false,
        "manufacturer": [
          {
            "manufacturer": {
              "reference": "Organization/cfsb2176224411725"
            }
          }
        ],
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code": "059QF0KO0R",
                  "display": "Water for injections"
                }
              ]
            }
          }
        }
      }
    },
    {
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cfsb4325643431772",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb4325643431772\" </p></div><p><b>identifier</b>: id: Hypersensitivity reaction (OFFICIAL)</p><p><b>type</b>: contraindication</p><p><b>subject</b>: </p><ul><li><a href=\"#MedicinalProductDefinition_cfsb1151803027115\">See above (MedicinalProductDefinition/cfsb1151803027115)</a></li><li><a href=\"MedicinalProductDefinition-cfsb7123030148537.html\">MedicinalProductDefinition/cfsb7123030148537</a></li></ul></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/rmswi/#/",
            "value": "Hypersensitivity reaction"
          }
        ],
        "type": "contraindication",
        "subject": [
          {
            "reference": "MedicinalProductDefinition/cfsb1151803027115"
          },
          {
            "reference": "MedicinalProductDefinition/cfsb7123030148537"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cfsb8699684597483",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb8699684597483\" </p></div><p><b>identifier</b>: id: Type 2 diabetes mellitus (OFFICIAL)</p><p><b>type</b>: indication</p><p><b>subject</b>: </p><ul><li><a href=\"#MedicinalProductDefinition_cfsb1151803027115\">See above (MedicinalProductDefinition/cfsb1151803027115)</a></li><li><a href=\"MedicinalProductDefinition-cfsb7123030148537.html\">MedicinalProductDefinition/cfsb7123030148537</a></li></ul></div>"
        },
        "identifier": [
          {
            "use": "official",
            "system": "https://spor.ema.europa.eu/rmswi/#/",
            "value": "Type 2 diabetes mellitus"
          }
        ],
        "type": "indication",
        "subject": [
          {
            "reference": "MedicinalProductDefinition/cfsb1151803027115"
          },
          {
            "reference": "MedicinalProductDefinition/cfsb7123030148537"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "DocumentReference",
        "id": "cfsb5671063821622",
        "text": {
          "status": "generated",
          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cfsb5671063821622\" </p></div><p><b>status</b>: current</p><p><b>description</b>: Instruksjonsfilm for bruk av ferdigfylt penn.</p><blockquote><p><b>content</b></p></blockquote></div>"
        },
        "status": "current",
        "description": "Instruksjonsfilm for bruk av ferdigfylt penn.",
        "content": [
          {
            "attachment": {
              "contentType": "video/mp4",
              "language": "no",
              "url": "https://www.felleskatalogen.no/medisin/film/suliqua-ferdigfylt-penn.mp4",
              "title": "Suliqua ferdigfylt penn",
              "creation": "2018-09-28",
              "height": 404,
              "width": 720,
              "duration": 366
            }
          }
        ]
      }
    }
  ]
}